Four molecular groups have been recently defined for endometrial carcinomas: the hypermutated (mismatch repair deficiency), the ultramutated (POLE mutated), the copy-number low (CN-low), and the copy-number high (CN-high) groups. Here, POLE is linked to endometrial carcinoma.